Clostridioides difficile infection enhanced surveillance

Clostridioides difficile infection (CDI) became a notifiable disease in May 2008. In August 2009, HPSC began collecting enhanced surveillance data on all CDI cases from acute hospitals on a voluntary basis. The enhanced surveillance collects information on both new and recurrent cases and also on the onset and origin of cases. Data is reported back to participants on a quarterly basis to enable hospitals monitor trends over time. **Purpose:** To provide the best possible information for the control and prevention of infectious diseases, by providing timely information and independent advice, and by carrying out disease surveillance, epidemiological investigation and related research and training. In scope: Includes healthcare (public and private hospitals and long-term care facilities) and community associated cases. Out of scope: Infection in children under 2 years of age. **Coverage:** Participation of hospitals is voluntary. In Q1 2022, 60 acute public (n=48) and private (n=12) hospitals provided data. Data collection start date in August 2009.